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Abstract
Background: Leiomyosarcoma of the rectum is a rare entity that comprises less than 0.1 % of all rectal
malignancies. Given the uncommon nature of this tumor and the controversy about its treatment we report
one case and review the literature in an attempt to report a particular evolution and to discuss the most
appropriate treatment.
Case presentation: This case report describes the presentation of leiomyosarcoma of the rectum. A
30-year-old man from the north of Morocco presented with rectorrhagia and constipation. On physical
examination we found a mass in his rectum approximately 6 cm from his anal margin. Pelvic magnetic
resonance imaging showed a rectal mass with a parietal attachment that invaded the fascia and his perirectal
tissue. Before any treatment he defecated spontaneously the tumor. On histopathological examination a
diagnosis of leiomyosarcoma was made. An anterior resection of his rectum was performed with adjuvant
radiotherapy at a dose of 50 Gy. After 1 year of surveillance, he has not presented any clinical symptoms and
pelvic magnetic resonance imaging was normal.
Unfortunately, histological analysis of a superficial biopsy of a rectal leiomyosarcoma may not be reflective of
the entire tumor mass, and a diagnosis is based essentially on postoperative pathological examination. The
optimal treatment modality in patients with rectal leiomyosarcomas is controversial. Prognosis is also poor;
tumor size, histological grade, mitotic index, and local staging are the most known prognosis factors.
Conclusion: The prognosis of rectal leiomyosarcoma is poor; more investigations are necessary to understand
the progression of these tumors and to define an optimal treatment modality.
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Background
Leiomyosarcoma of the rectum is a rare malignant
tumor representing less than 0.1 % of all rectal malig-
nancies [1]. People can have this tumor at any age
but it has a particular predilection for the fifth and
sixth decades of life and it occurs more frequently in
men. Given this uncommon localization of leiomyo-
sarcoma, our case report adds another case to the lit-
erature and we will review available data in the
literature.
Case presentation
We describe the case of a 30-year-old man from the
north of Morocco with no medical or surgical history
and no family history of rectal disease. His dietary habits
were characterized by a well-balanced consumption of
meat and vegetables. He presented with a 1-year history
of rectorrhagia and constipation.
A digital rectal examination and rectoscopy revealed a
mass in a left posterolateral position in his rectum ap-
proximately 6 cm from his anal margin that extended up
to 10 cm; the tumor was not mobile. The rest of his phys-
ical examination was normal. During rectoscopy, the
tumor was biopsied and histological analysis gave no evi-
dence of malignancy. An abdominal and pelvic magnetic
resonance imaging revealed an approximately 7.5-cm
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heterogeneous mass in his rectum. The tumor presented a
parietal pedicle with an implantation base of 4 cm and in-
vaded the fascia and the perirectal tissue. There was no
evidence of distant metastasis (Figs. 1 and 2).
On biologic examination, his hemoglobin was 10 g/dl
and his white blood cells were 7000. His renal function
was correct and creatinine clearance was 120 ml/minute.
Hepatitis B and C serology was negative. He was hospi-
talized in our surgical department when he defecated
spontaneously the tumor mass.
Macroscopic pathology examination showed a large
fleshy lobulated mass measuring 8 × 5 × 3 cm, with foci
of hemorrhage. Microscopic examination revealed a cel-
lular tumor arranged in interlacing bundles of spindle-
shaped cells, with a marked cellular pleomorphism, a
large and hyperchromatic nuclei, and abundant eosino-
philic cytoplasm. Mitotic figures (12 per 10 high-power
fields) and atypical mitotic figures were also noted. Immu-
nohistochemistry revealed that neoplastic cells expressed
desmin, h-caldesmon, and smooth muscle actin, and ex-
hibited negative staining for CD117, CD34, and S-100.
Subsequently, a diagnosis of grade II leiomyosarcoma was
retained (Figs. 3 and 4).
He had an anterior rectal resection 15 days later; there
were no stigma of macroscopic tumor perioperatively.
An anatomopathologic examination did not find any re-
sidual malignancy.
This case was discussed in a multidisciplinary meeting.
Because of the initial tumor size and the differentiation
degree, postoperative pelvic radiotherapy was indicated
for the purpose of improving local control. Three-
dimensional radiotherapy of the tumor bed was deliv-
ered using three fields (anterior, lateral left, and lateral
right), the total prescribed dose was 50 Gy in 2 Gy per
fraction, and the treatment duration was 36 days. At the
end of radiotherapy, he had follow-up consultation every
3 months. At 1-year post-radiotherapy he is doing well
and has no symptoms. Magnetic resonance imaging of
his pelvis performed at 6 months post-radiotherapy
showed no sign of recurrence (Figs. 5 and 6).
Discussion
Leiomyosarcomas are malignant mesenchymal tumors
arising from smooth muscle cells. Primary rectal leio-
myosarcomas are rare and constitute less than 0.1 % of
colorectal malignancies [1, 2], and the prognosis is still
poor [3]. The differentiation between benign leiomyomas
of the rectum and leiomyosarcomas may be difficult be-
cause they have identical clinical and radiologic manifes-
tations, and the final diagnosis needs to be confirmed by
pathological examination. Unfortunately, histological
analysis of superficial biopsy specimens may not be re-
flective of the entire tumor mass and leiomyosarcomas
can be misdiagnosed as benign leiomyomas. Some stud-
ies suggest the preoperative histological diagnosis of rec-
tal tumors is adequate in only 29 % of cases [4]. In our
case the histological type was not determined even with
two biopsies of the rectum; the final diagnostic was
Fig. 1 Image showing axial view of a T2-weighted magnetic resonance
image of the pelvis, which showed a mass in the rectum
Fig. 2 Image showing sagittal view of a T2-weighted magnetic
resonance image of the pelvis, which showed a mass in the rectum
Fig. 3 Microscopic examination showing spindle cells proliferation,
with nuclei of various sizes and shapes
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retained on the pathological analysis of the expulsed
tumor.
On macroscopic examination, leiomyosarcoma is usu-
ally large and of a rubbery firm consistency, adherent to
the surrounding tissues. Foci of necrosis hemorrhage
and cystic degeneration may be seen [5]. On histopatho-
logic examination, typical leiomyosarcoma is character-
ized by sheets of densely packed spindle cells; neoplastic
cells are elongated with abundant fibrillar eosinophilic
cytoplasm. Centrally placed, the nucleus is usually blunt-
ended or “cigar-shaped.” In some cells, a vacuole is seen
at one end of the nucleus. In poorly differentiated tu-
mors the nucleus is more pleomorphic. Multinucleated
giant cells may be seen. Necrosis, hemorrhage, and mi-
totic figures are frequent in these pleomorphic tumors.
On immunohistochemical examination, the tumor cells
express smooth muscle cell markers: HHF35, desmin,
smooth muscle myosin heavy chain, h-caldesmon, and
recently transgelin [5, 6].
Leiomyosarcoma must be distinguished from fibroma-
toses, schwannomas, and gastrointestinal stromal tumor
(GIST). In fact, leiomyosarcomas are composed of cells
that consistently express smooth cell actin and desmin,
but they are negative for CD34 and CD117, these last
are positive in the case of GIST [7].
The optimal treatment modality in patients with rectal
leiomyosarcomas remains controversial. Radical surgery,
such as anterior resection or abdominoperineal resec-
tion, is preferred to wide local excision. In fact, radical
surgery is associated with a lower recurrence rate than
wide local excision. Khalifa et al., in a review of 135
cases of rectal leiomyosarcoma, found a local recurrence
rate of 67.5 % with local excision, compared to only
19.5 % with abdominoperineal resection, but there were
no differences in survival rates between the two surgery
modalities [8–10]. In addition, Anderson et al. stated
that local excisions of rectal leiomyosarcomas were al-
most always followed by recurrence no matter what
grade of malignancy [11]. However, Quan and Berg also
believed that wide local excision provided adequate local
control for tumors less than 2.0 cm [12].
Because leiomyosarcoma is a relatively radioresistant
tumor, and patients with rectal leiomyosarcoma can de-
velop early hematogenous metastases, adjuvant pelvic ra-
diation therapy is generally considered unsuccessful, as
for Tjandra et al. adjuvant radiation therapy is not effect-
ive [13]. In contrast, Minsky et al. [14] reported that ra-
diation therapy following conservative surgery can be an
alternative to radical surgery with the goals of local con-
trol of the disease and rectal sphincter preservation. Ad-
juvant radiotherapy can be proposed by extension of the
management principles of other pelvic tumor types and
limb sarcomas, given the absence of randomized clinical
trials. Chemotherapy has been generally unsuccessful in
treating this tumor. The two most commonly used agents
are doxorubicin and dacarbazine [15]. Histopathological
Fig. 4 Positive immunostaining for desmin
Fig. 5 Image showing axial view of a T2-weighted magnetic resonance
image of the pelvis, which showed no evidence of recurrence
Fig. 6 Image showing sagittal view of a T2-weighted magnetic
resonance image of the pelvis, which showed no evidence of recurrence
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characteristics predictive of poor prognosis include high
mitotic activity, intratumoral necrosis, and tumor size [16].
In our case, the evolution was unusual compared to
other reported cases, with spontaneous expulsion of the
entire tumor through the rectum, it may be explained by
the necrosis of the tumor pedicle. We did not find cases
with such an evolution in the literature, but we found
some cases of spontaneous expulsion of ileal lipoma per
rectum [17, 18]. As in our case, the mass was connected
to the rectum by a pedicle. The gravity of the tumor and
the presence of intestinal peristalsis gave rise to ische-
mia, necrosis, and breakage of the pedicle. Thus, the
tumor fell from the rectum.
Conclusions
Leiomyosarcomas of the rectum are rare tumors with
few cases published in the literature. The diagnosis is
confirmed by postoperative pathological examination;
the overall prognosis is poor with reported survival of 20
to 40 % at 5 years [19]. In view of the rarity of leiomyo-
sarcoma of the rectum, there will probably never be any
possibility of a randomized clinical trial to assess the op-
timal treatment; however, adjuvant radiotherapy can be
proposed by extension of the management principles of
other pelvic tumor types and limb sarcomas.
Abbreviation





Availability of data and materials
The datasets during and/or analyzed during the current study are available
from the corresponding author on reasonable request.
Authors’ contributions
NS, HE, and JK wrote the manuscript and reviewed the literature. MK and BE
performed the histological examination of the rectal tumor. SE was a major
contributor in writing the manuscript. TK and NB corrected the manuscript
before submission. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication of
this case report and accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of this journal.
Ethics approval and consent to participate
Not applicable.
Author details
1Department of Radiotherapy, National Institute of Oncology, University
Mohammed V, Rabat, Morocco. 2Department of Pathology, National Institute
of Oncology, University Mohammed V, Rabat, Morocco.
Received: 29 January 2016 Accepted: 29 August 2016
References
1. Walsh TH, Mann CV. Smooth muscle neoplasms of the rectum and anal
canal. Br J Surg. 1984;71(8):597e9.
2. Campos FG, Leite AF, Araújo SE, et al. Anorectal leiomyomas: report of two
cases with different anatomical patterns and literature review. Rev Hosp Clin
Fac Med Sao Paulo. 2004;59:296–301.
3. Wang TK, Chung MT. Anorectal leiomyosarcomas. J Gastroenterol. 1998;
33(3):402–7.
4. Chiara O, Canini T, Segala M, Tiberio GA, Giulini SM, Tiberio G. Smooth-
muscle-cell tumors of the gastroenteric tract. A review of cases. Minerva
Chir. 1997;52(10):1147–55.
5. Weiss SW, Goldblum JR. Enzinger and Weiss’s soft tissue tumors. 5th ed. St
Louis: Mosby; 2008. p. 546–55.
6. Robin YM, Penel N, Pérot G, et al. Transgelin is a novel marker of smooth
muscle differentiation that improves diagnostic accuracy of
leiomyosarcomas: a comparative immunohistochemical reappraisal of
myogenic markers in 900 soft tissue tumors. Mod Pathol. 2013;26(4):502–10.
7. Koyuncuer A, Gönlüşen L, Kutsal AV. A rare case of giant gastrointestinal
stromal tumor of the stomach involving the serosal surface. Int J Surg Case
Rep. 2015;12:90–4. doi:10.1016/j.ijscr.2015.04.037.
8. Diamante M, Bacon HE. Leiomyosarcoma of the rectum: report of a case.
Dis Colon Rectum. 1967;10:347–51.
9. Khalifa AA, Bong WL, Rao VK, Williams MJ. Leiomyosarcoma of the rectum. Report
of a case and review of the literature. Dis Colon Rectum. 1986;29:427–32.
10. Ncner FD, Stoeckinger JM, Evan OT. Smooth muscle rectal tumors: A
therapeutic dilemma. Dis Colon Rectum. 1977;20:405–13.
11. Anderson PA, Dockerty MB, Bale LA. Myomatous tumours of the rectum
(leiomyomas and myosarcomas). Surgery. 1950;28(4):642–50.
12. Quan SH, Berg JW. Leiomyoma and leiomyosarcoma of the rectum. Dis
Colon Rectum. 1962;5:415–25. 642–50.
13. Tjandra JJ, Antoniuk PM, Webb B, Petras RE, Fazio VW. Leiomyosarcoma of
the rectum and anal canal. Aust NZ J Surg. 1993;63:703–9.
14. Minsky BD, Cohen AM, Hadju SI, Nori D. Sphincter preservation in rectal
sarcoma. Dis Colon Rectum. 1990;33:319–22.
15. Bramwell VH, Mouridsen HT, Santoro A, Blackledge G, Somers R, Verwey J,
Dombernowsky P, Onsurd M, Thomas D, Sylvester R. Cyclophosphamide vs.
ifosfamide: final report of a randomized phase II trial in adult soft tissue
sarcomas. Eur J Cancer Clin Oncol. 1987;23:311.
16. Hatch KF, Blanchard DK, Hatch GF, Wertheimer-Hatch L, Davis GB, Foster RS,
Skandalakis JE. Tumors of the rectum and anal canal. World J Surg. 2000;24:437–43.
17. Kang B, Zhang Q, Shang D, Ni Q, Muhammad F, Hou L, Cui W. Resolution of
intussusception after spontaneous expulsion of an ileal lipoma per rectum:
a case report and literature review. World J Surg Oncol. 2014;12:143.
18. Misra SP, Singh SK, Thorat VK, Gulati P, Malhotra V, Anand BS. Spontaneous
expulsion per rectum of an ileal lipoma. Postgrad Med J. 1988;64:718–9.
19. Zbar AP, Sokolowsky N, Sandiford N, Prussia PR. Leiomyosarcoma of the
rectum. A report of two cases and review of the literature. West Indian Med
J. 2004;53:122–5.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Sahli et al. Journal of Medical Case Reports  (2016) 10:249 Page 4 of 4
